Plasma adrenomedullin concentrations in patients with renovascular or malignant hypertension

C Caliumi1, R Cianci, M Celi

  • 1Department of Clinical Sciences, University of Rome La Sapienza, Rome, Italy.

Abstract

Insights

Plasma adrenomedullin (AM) levels increase with arterial hypertension severity. Elevated AM in malignant (MHT) and renovascular hypertension (RVH) suggests renin-angiotensin system (RAS) activation contributes to higher AM levels.

Area of Science:

  • Cardiovascular Research
  • Endocrinology
  • Hypertension Studies

Background:

  • Adrenomedullin (AM) is a hypotensive peptide.
  • Malignant (MHT) and renovascular hypertension (RVH) involve renin-angiotensin system (RAS) activation.
  • Investigating AM behavior in hypertension is crucial.

Purpose of the Study:

  • To investigate plasma AM levels in MHT and RVH patients.
  • To compare AM levels with essential hypertensive patients (EHT) and normotensive subjects (NS).
  • To explore the relationship between RAS activation and AM levels.

Main Methods:

  • Studied 4 MHT, 10 RVH, 24 EHT patients, and 21 NS.
  • Collected 10 ml venous blood samples.
  • Measured plasma AM using radioimmunoassay; measured plasma renin activity (PRA).

Main Results:

  • Plasma renin activity (PRA) was significantly higher in RVH and MHT patients.
  • Plasma AM levels were significantly elevated in EHT and RVH compared to NS.
  • Plasma AM levels were highest in MHT patients and decreased after treatment.

Conclusions:

  • Plasma AM concentrations increase proportionally with arterial hypertension severity.
  • RAS activation in MHT and RVH patients may contribute to elevated plasma AM levels.
  • Findings highlight AM as a potential biomarker in hypertensive conditions.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...